Dare Bioscience, Inc. (DARE) Free cash flow 2016–2025
Dare Bioscience, Inc. (DARE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.3MFY2025 · since FY2016: -$907,299 → -$10.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.3M | -309.6% |
| FY2024 | $4.9M | +112.4% |
| FY2023 | -$39.5M | -117.5% |
| FY2022 | -$18.2M | +36.9% |
| FY2021 | -$28.8M | -14.0% |
| FY2020 | -$25.3M | -89.6% |
| FY2019 | -$13.3M | -29.5% |
| FY2018 | -$10.3M | -304.7% |
| FY2017 | -$2.5M | -180.0% |
| FY2016 | -$907,299 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice